Phenotypic alterations in ductal carcinoma in situ-associated myoepithelial cells: Biologic and diagnostic implications

American Journal of Surgical Pathology

Volumn 33, Issue 2, 2009, Pages 227-232

  Hilson, Justin B ^a   Schnitt, Stuart J ^a   Collins, Laura C ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Breast cancer; Ductal carcinoma in situ; Myoepithelial cells

Indexed keywords

BIOLOGICAL MARKER; CALPONIN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKERATIN 5; CYTOKERATIN 6; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN KINASE; PROTEIN P63; PROTEIN P75; SMOOTH MUSCLE ACTIN; UNCLASSIFIED DRUG; TUMOR MARKER;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MYOEPITHELIUM CELL; PHENOTYPE; BREAST TUMOR; EPITHELIUM CELL; FEMALE; METABOLISM; MUSCLE CELL; PATHOLOGY;

BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MUSCLE CELLS; PHENOTYPE; TUMOR MARKERS, BIOLOGICAL;

EID: 60249102093     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e318180431d     Document Type: Article

References (22)

1. Adriance MC, Inman JL, Petersen OW, et al. Myoepithelial cells: good fences make good neighbors. Breast Cancer Res. 2005;7: 190-197.
2. Allinen M, Beroukhim R, Cai L, et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell. 2004; 6:17-32.
3. Arpino G, Laucirica R, Elledge RM. Premalignant and in situ breast disease: biology and clinical implications. Ann Intern Med. 2005; 143:446-457.
4. Barsky SH, Karlin NJ. Mechanisms of disease: breast tumor pathogenesis and the role of the myoepithelial cell. Nat Clin Pract Oncol. 2006;3:138-151.
5. Bhargava R, Dabbs DJ. Use of immunohistochemistry in diagnosis of breast epithelial lesions. Adv Anat Pathol. 2007;14:93-107.
6. Burstein HJ, Polyak K, Wong JS, et al. Ductal carcinoma in situ of the breast. N Engl J Med. 2004;350:1430-1441.
7. Deugnier MA, Teuliere J, Faraldo MM, et al. The importance of being a myoepithelial cell. Breast Cancer Res. 2002;4:224-230.
8. Hu M, Yao J, Cai L, et al. Distinct epigenetic changes in the stromal cells of breast cancers. Nat Genet. 2005;37:899-905.
9. Kalof AN, Tam D, Beatty B, et al. Immunostaining patterns of myoepithelial cells in breast lesions: a comparison of CD10 and smooth muscle myosin heavy chain. J Clin Pathol. 2004;57:625-629.
10. Krishnamurthy S, Sneige N. Molecular and biologic markers of premalignant lesions of human breast. Adv Anat Pathol. 2002;9: 185-197.
11. Lakhani SR, O'Hare MJ. The mammary myoepithelial cell - Cinderella or ugly sister? Breast Cancer Res. 2001;3:1-4.
12. Leonard GD, Swain SM. Ductal carcinoma in situ, complexities and challenges. J Natl Cancer Inst. 2004;96:906-920.
13. Lerwill MF. Current practical applications of diagnostic immuno-histochemistry in breast pathology. Am J Surg Pathol. 2004;28: 1076-1091.
14. Moulis S, Sgroi DC. Re-evaluating early breast neoplasia. Breast Cancer Res. 2008;10:302.
15. Polyak K, Hu M. Do myoepithelial cells hold the key for breast tumor progression? J Mammary Gland Biol Neoplasia. 2005;10: 231-247.
16. Shackney SE, Silverman JF. Molecular evolutionary patterns in breast cancer. Adv Anat Pathol. 2003;10:278-290.
17. Simpson PT, Reis-Filho JS, Gale T, et al. Molecular evolution of breast cancer. J Pathol. 2005;205:248-254.
18. Sternlicht MD, Barsky SH. The myoepithelial defense: a host defense against cancer. Med Hypotheses. 1997;48:37-46.
19. Sternlicht MD, Kedeshian P, Shao ZM, et al. The human myoepithelial cell is a natural tumor suppressor. Clin Cancer Res. 1997;3: 1949-1958.
20. Wang NP, Bing BC, Skelly M, et al. Antibodies to novel myoepithelium-associated proteins distinguish benign lesions and carcinoma in situ from invasive carcinoma of the breast. Appl Immunohistochem. 1997;5:141-151.
21. Yeh IT, Mies C. Application of immunohistochemistry to breast lesions. Arch Pathol Lab Med. 2008;132:349-358.
22. Zhang RR, Man Y-G, Vang R, et al. A subset of morphologically distinct mammary myoepithelial cells lacks corresponding immunophenotypic markers. Breast Cancer Res. 2003;5:R151-R156.